Skip to content
  • Why We Age
  • Viral Shockwave

clinicaltrialist.com

  • LinkedIn
  • Email
  • Drug Development
    • Clinical
    • Paradoxes
    • Productivity
    • What We Get Wrong
    • New Discoveries
  • A New Look at Biology
    • Biological Insights
    • Aging and (Im)mortality
    • Controversies
    • Germs
    • Sleep
    • Drug Development for Layperson
    • OneHealth
  • Managing Startups
    • Management
    • Managing A Public Company
  • Links & Info
    • My Textbooks
    • Recommended Books
    • Key Papers
    • Longevity Links
    • Breakthrough Technologies
    • Blogroll
    • Miscellaneous Links
  • Orthogonal Concepts
    • Phase Transition
    • Black Swan
  • About
    • About Me
    • Contact
  • Manage Subscriptions

Manage Subscriptions

Send Login Link

Please fill in your subscriber email address below to get a login link.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
  • Click to share on Reddit (Opens in new window)

Like this:

Like Loading...
Blog Posts
My Textbooks
Principles and Practice of Clinical Trial Medicine
Global Clinical Trials
Global Clinical Trials Playbook
Adaptive and Flexible Clinical Trials
Clinical Trialists I've Trained
  • Sheila Gujrathi, Chief Executive Officer at Gossamer Bio
  • Naveed Shams, Head of Global R&D and Chief Scientific Officer, Santen
  • June Lee, Chief Operating Officer at MyoKardia
  • Charlie Semba, Chief Medical Officer at Graybug Vision
  • Sunil Agarwal, President of Research and Development Juno Therapeutics
  • Robert Kim, Chief Medical Officer at Apellis Pharmaceuticals
  • Yamo Deniz, Former Chief Medical Office at GE Healthcare Diagnostics
  • Paul Kwon, Chief Medical Officer at Menlo Therapeutics
  • Elena Hitraya, Chief Medical Officer at Crescendo Bioscience
  • Paul Brunetta, Senior Vice President, Translational Sciences at Juno Therapeutics
  • Wolfgang Dummer, Former Vice President of Clinical Science, Biomarin
About Me

Richard Chin is the Managing Director of Ascendant Venture; CEO of AdoraPet, a biotech creating healthier pets; and CEO of Infinita Life, a biotech pursuing a cure for aging. Previously, he was the Founder and CEO of KindredBio (NASDAQ:KIN), a biotech developing pet therapeutics. His expertise is in clinical development and he has authored several books on clinical trials. More

The posts and opinions on this site are my own and do not necessarily represent those of KindredBio.

Nothing on this blog is medical advice. Do what your doctor tells you to do. Do not do anything she tells you not to do.

Find us on
  • LinkedIn
  • Email
Powered by WordPress.com.
%d bloggers like this: